A pilot study of infusional CMF (CMF-inf): Active and well tolerated in breast cancer

Annals of Oncology

Volumn 7, Issue 4, 1996, Pages 409-411

  Mackay, J ^a   Cameron, D A ^a   Gardiner, J ^a   Leonard, T ^a   Lee, L E ^a   Leonard, R C F ^a  

^a NHS LOTHIAN   (United Kingdom)

Author keywords

5 fluorouracil; Breast cancer; CMF; Infusional

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

ADULT; ARTICLE; BOLUS INJECTION; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MUCOSA INFLAMMATION; NEUTROPENIA; PRIORITY JOURNAL; UREMIA; VOMITING;

EID: 0030037125     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010609     Document Type: Article

References (11)

1. Ng JSY, Cameron DA, Lee L et al. Infusional 5-fluorouracil as a single agent in relapsed breast cancer: Its activity and toxicity. The Breast 1994; 3: 87-9.
2. Cameron DA, Gabra H, Leonard RCF. Continuous 5-fluorouracil in the treatment of breast cancer. Br J Cancer 1994; 70: 120-4.
3. Englesman E, Klyn JCM, Rubens RD et al. Classical CMF versus 3 weekly intravenous CMF schedule in post-menopausal patients with advanced breast cancer. Eur J Cancer 1991; 27: 966-70.
4. Curreri AR, Ansfield FJ, McIver FA et al. Clinical studies with 5-fluorouracil. Cancer Res 1958; 18: 478-84.
5. Ansfield F, Klotz J, Nealon T et al. A phase III study of comparing the clinical utility of four regimens of 5-fluorouracil. Cancer 1977; 39: 24-40.
6. Lokich JJ, Ahlgreen JD, Gullo JJ et al. A prospective randomised comparison of continuous infusion fluorouracil with conventional bolus schedule in metastatic colorectal carcinoma: A mid-Atlantic oncology program study. J Clin Oncol 1989; 7: 425-32.
7. Hansen R, Quebbeman E. Beatty P et al. Continuous 5-fluorouracil infusion in refractory carcinoma of the breast. Breast Cancer Res Treat 1987; 10: 145-9.
8. Huan S, Pazdar R, Singhakowinta A et al. Low dose continuous infusion 5-fluorouracil: Evaluation in advanced breast carcinoma. Cancer 1989; 63: 419-22.
9. Sapher T, Tormey DC, Cary P. Continuous infusion 5-fluorouracil combined with doxorubicin and cyclophosphamide: Feasibility study. Med Paediatr Oncol 1992; 20(4): 321-4.
10. Jones AL, Smith IE, O'Brien MER et al. Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer - an active new regimen. J Clin Oncol 1994; 12: 1259-65.
11. Lokich JJ, Moore C. Chemotherapy - associated palmarplantar erythrodysesthesia syndrome. Ann Intern Med 1984; 101: 798-9.